Discover 1 curated intelligence briefings related to this specific topic.
The longevity industry is pivoting from mouse models to human clinical data. New research into senolytics—drugs that flush out 'zombie cells'—is opening frontiers in osteoporosis, Alzheimer's, and skin rejuvenation, powered by AI and a global biotech circuit.
